Portfolio (Quarterly)
Guide ↗
Soleus Capital Management, L.P.
· CIK 0001802630| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | KRYS | KRYSTAL BIOTECH INC | Healthcare | 939,254.0 | $349.1M | 12.03% | -214K | -18.5% | $371.67 | -3.2% |
| 2 | TGTX | TG THERAPEUTICS INC | Healthcare | 2,927,895.0 | $160.9M | 5.54% | -1.1M | -27.3% | $54.94 | +0.2% |
| 3 | NVCR | NOVOCURE LTD | Healthcare | 9,913,401.0 | $150.2M | 5.17% | -579K | -5.5% | $15.15 | +18.1% |
| 4 | VCEL | VERICEL CORP | Healthcare | 1,459,152.0 | $64.9M | 2.24% | -1.1M | -42.8% | $44.49 | -4.6% |
| 5 | — | PRAXIS PRECISION MEDICINES I | — | 177,517.0 | $59.4M | 2.05% | -153K | -46.3% | $334.79 | — |
| 6 | ALKS | ALKERMES PLC | Healthcare | 1,029,252.0 | $53.9M | 1.86% | -942K | -47.8% | $52.40 | -6.2% |
| 7 | NPCE | NEUROPACE INC | Healthcare | 2,911,122.0 | $46.3M | 1.59% | -21K | -0.7% | $15.89 | -7.6% |
| 8 | PGNY | PROGYNY INC | Healthcare | 1,602,000.0 | $46.2M | 1.59% | -465K | -22.5% | $28.83 | -8.5% |
| 9 | INDV | INDIVIOR PHARMACEUTICALS INC | Healthcare | 1,064,000.0 | $43.7M | 1.50% | -210K | -16.5% | $41.03 | -12.7% |
| 10 | — | GLOBUS MED INC | — | 468,922.0 | $37.0M | 1.28% | -261K | -35.7% | $79.01 | — |
| 11 | SNDX | SYNDAX PHARMACEUTICALS INC | Healthcare | 1,628,039.0 | $35.6M | 1.23% | -99K | -5.7% | $21.86 | -8.1% |
| 12 | TRVI | TREVI THERAPEUTICS INC | Healthcare | 1,179,618.0 | $22.0M | 0.76% | -440K | -27.2% | $18.65 | -3.9% |
| 13 | BMRN | BIOMARIN PHARMACEUTICAL INC | Healthcare | 375,572.0 | $21.5M | 0.74% | -275K | -42.3% | $57.22 | +14.7% |
| 14 | LIVN | LIVANOVA PLC | Healthcare | 254,957.0 | $21.0M | 0.72% | -328K | -56.2% | $82.23 | -2.7% |
| 15 | EWTX | EDGEWISE THERAPEUTICS INC | Healthcare | 450,889.0 | $18.3M | 0.63% | -999K | -68.9% | $40.63 | +9.2% |
| 16 | XENE | XENON PHARMACEUTICALS INC | Healthcare | 267,000.0 | $16.1M | 0.56% | -25K | -8.6% | $60.36 | +5.7% |
| 17 | CCCC | C4 THERAPEUTICS INC | Healthcare | 3,377,981.0 | $15.8M | 0.54% | -426K | -11.2% | $4.67 | -9.2% |
| 18 | — | KINIKSA PHARMACEUTICALS INTL | — | 246,353.0 | $15.8M | 0.54% | -275K | -52.8% | $63.95 | — |
| 19 | TWST | TWIST BIOSCIENCE CORP | Healthcare | 104,629.0 | $10.8M | 0.37% | -1.1M | -91.5% | $102.88 | +45.9% |
| 20 | VIR | VIR BIOTECHNOLOGY INC | Healthcare | 1,000,000.0 | $10.2M | 0.35% | -1.0M | -50.0% | $10.19 | +8.7% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
100.0%